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7METHODOLOGY ARTICLE Open AccessIsothermal loop-mediated amplification
(lamp) for diagnosis of contagious bovine
pleuro-pneumonia
Georg Mair1,2, Edy M Vilei3,6, Abel Wade4, Joachim Frey3 and Hermann Unger5*Abstract
Background: Contagious Bovine Pleuropneumonia (CBPP) is the most important chronic pulmonary disease of
cattle on the African continent causing severe economic losses. The disease, caused by infection with Mycoplasma
mycoides subsp. mycoides is transmitted by animal contact and develops slowly into a chronic form preventing an
early clinical diagnosis. Because available vaccines confer a low protection rate and short-lived immunity, the rapid
diagnosis of infected animals combined with traditional curbing measures is seen as the best way to control the
disease. While traditional labour-intensive bacteriological methods for the detection of M. mycoides subsp. mycoides
have been replaced by molecular genetic techniques in the last two decades, these latter approaches require
well-equipped laboratories and specialized personnel for the diagnosis. This is a handicap in areas where CBPP is
endemic and early diagnosis is essential.
Results: We present a rapid, sensitive and specific diagnostic tool for M. mycoides subsp. mycoides detection
based on isothermal loop-mediated amplification (LAMP) that is applicable to field conditions. The primer set
developed is highly specific and sensitive enough to diagnose clinical cases without prior cultivation of the
organism. The LAMP assay detects M. mycoides subsp. mycoides DNA directly from crude samples of pulmonary/
pleural fluids and serum/plasma within an hour using a simple dilution protocol. A photometric detection of
LAMP products allows the real-time visualisation of the amplification curve and the application of a melting
curve/re-association analysis presents a means of quality assurance based on the predetermined strand-inherent
temperature profile supporting the diagnosis.
Conclusion: The CBPP LAMP developed in a robust kit format can be run on a battery-driven mobile device to
rapidly detect M. mycoides subsp. mycoides infections from clinical or post mortem samples. The stringent innate
quality control allows a conclusive on-site diagnosis of CBPP such as during farm or slaughter house inspections.
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Contagious Bovine Pleuropneumonia (CBPP) caused by
Mycoplasma mycoides subsp. mycoides (previously further
specified as Small Colony (SC) type) (Manso-Silván et al. [1])
is considered as the main plague of cattle in Africa since the
eradication of rinderpest (Roeder [2]). In recent years, CBPP
re-emerged from where it had persisted and has spread to* Correspondence: h.unger@iaea.org
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reproduction in any medium, provided the orareas from which it had previously been eradicated, thus
stimulating new, large-scale efforts to contain or possibly
eradicate epidemics (www.fao.org). The pathogen is consid-
ered highly contagious and often there is only a slow devel-
opment of clinical signs. Current vaccines against CBPP
confer only partial and short-lived protection and there is
some concern regarding their biosafety (Mbulu et al. [3];
Thiaucourt et al. [4]; Wesonga et al. [5]). Hence, rapid and
reliable diagnosis of CBPP combined with traditional control
measures including reduction of animal movement and iso-
lation or stamping-out of affected animals, remains the most
efficient way to control the disease. Serological methods are
generally used for determining the CBPP status at herd level. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Nucleotide sequences of the CBPP LAMP primers
used
Msc3.
1-F3
ACTACTTGTTGTTGTAGTGTTTG
Msc3.
1-B3
ATGGTGGTTTATCAAATGATGA
Msc3.
1-FIP
TCAAAGAGATAATTCTACTTCAGCTAAGGATCCTGAAGAACCAGAA
Msc3.
1-BIP
TCTAGCAGAATTTTTTGCACTTAACAAAGTTGATAACGCAATAGAGC
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Thiaucourt [8]; Muuka et al. [9]; Schubert et al. [10];
Tardy et al. [11]). Bacterial isolation is still the reference
method for detection of the pathogen. However, bacterial
cultivation of mycoplasma species in general and subse-
quent identification is cumbersome due to the fastidious
growth requirements of these bacteria.
During the last two decades, several conventional and
real-time PCR methods (qPCR) for rapid diagnosis of
CBPP and early outbreak warning have been developed
(Bashirrudin et al. [12]; Fitzmaurice et al. [13]; Lorenzon
et al. [14]; Miserez et al. [15]; Schnee et al. [16]; Vilei
and Frey [17]). Although such methods are specific and
sensitive they depend on a laboratory infrastructure with
sophisticated equipment and highly trained personnel.
Most PCR protocols for CBPP diagnosis rely on the sam-
ples being pre-enriched for mycoplasmas and/or require
expensive and laborious extraction methods. Such methods
are not generally available in the rural areas of Africa where
CBPP is possibly endemic and rapid diagnosis of the disease
is essential. Another issue is that transportation of infected
samples over long distances drastically affects the viability
of the bacteria rendering them unfit for culturing and/or
resulting in spoilage of the nucleic acid. To address the
need for an in-the-field diagnostic method for CBPP, an
isothermal loop-mediated amplification (LAMP) has been
developed (Notomi et al. [18]). This is based on autocycling
DNA synthesis under isothermal conditions in the presence
of a thermophilic strand-displacing DNA polymerase that
contains the 5’→ 3’ polymerase activity but lacks 5’→ 3’
exonuclease activity (such as Bst or Bsm polymerase). The
technique uses four specific primers recognizing six distinct
regions on the DNA template (Notomi et al. [18]). The
CBPP LAMP developed is fulfilling most of the criteria for
an Affordable, Sensitive, Specific, User-friendly, Robust
and rapid, Equipment free and Deliverable to the end user
(ASSURED) diagnostic system (Mabey et al. [19]).
Methods
Mycoplasma strains and DNA extraction
In this study, 83 strains of mycoplasmas representing 17
different species or subspecies including 28 isolates of M.
mycoides subsp. mycoides were used (Additional file 1:
Table S1). Mycoplasmas were grown in a standard medium
(Axcell Biotechnologies, St. Genis l’Argentière, France)
at 37°C to a density of 108–109 colony-forming units
(CFU) per ml or on solid mycoplasma agar medium
(Axcell Biotechnologies). Handling of live M. mycoides
subsp. mycoides was performed in a biological safety la-
boratory fulfilling the BL3 containment safety standards.
Lysis of mycoplasmas with GES buffer (5 M guanidium
thiocyanate, 100 mM EDTA, 0.5%N-lauroylsarcosine)
and extraction of genomic DNA were performed as pre-
viously described (Pilo et al. [20]).Clinical samples
To allow for the use of the LAMP for diagnosis in the
field, the amplification should effectively work without
the need to extract DNA. This was studied using clinical
samples of pleural fluid and bronchial lavage. Sequential
bronchial lavage fluids were collected from cattle during
an earlier experimental infection trial (Miserez et al. [15];
ethical approval by Swiss Federal Ministry of Veterinary
Affairs). In addition, simulated clinical samples consisting
of M. mycoides subsp. mycoides suspension supplemented
with blood or squeezed liver tissues were prepared. The
samples from inoculated cattle from Cameroun were
from a vaccination trial (ethically approval by the board of
directors of LANAVET, Cameroun; 2010).
Sample preparation
Samples (1.5 μl) were added to 25 μl of LAMP buffer
(66 mM Tris-HCl pH 8.8, 32 mM KCl, 32 mM (NH4)2SO4,
16 mM MgCl2, 0.3% (v/v) Tween 20) and heated for five
minutes at 95°C (a process available in the reading device),
followed by immediate chilling and pulse centrifugation
to sediment precipitates. Chilling was necessary before
addition to the LAMP master mix to avoid damaging
the strand displacement polymerase.
LAMP primer design
The gene sequence encoding a putative pro-lipoprotein
of M. mycoides subsp. mycoides, locus tag MSC_0500
(GenBank accession number: BX293980.2 from the
type strain PG1; Westberg et al. [21]) was selected for
primer design. Since the initial primer design with
PrimerExplorer 3.0 (Eicken, Japan; http://primerexplorer.
jp/elamp3.0.0/index.html) did not yield a performing
primer set (high GC content), we first designed the outer
primers Msc3.1-F3 and Msc3.1-B3 (Table 1) with Primer
Express 2.0 (Life Technologies, Grand Island NY, USA)
according to the heat map profile. These colder sequences
were then applied to PrimerExplorer 3.0 for the design of
the inner primers Msc3.1-FIP and Msc3.1-BIP (Table 1).
The melting temperatures (Tm) of the resulting primer
sequences were all in the range of 56°C. Primers were then
tested for hairpin structures, extensible primer hybrids
and specificity by NetPrimer (PREMIER Biosoft, USA;
Figure 1 Sensitivity of the CBPP LAMP: Titration curve based
on diluted culture samples of M. mycoides subsp. mycoides
strain Afadé directly employed in the reaction.
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and Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/).
LAMP reaction conditions
The total volume of the LAMP assays was 25 μl i.e.
15 μl of LAMP buffer including the sample and 10 μl of
master mix for final concentrations of 460 mM trehalose
(alternative enhancer), 0.4 mM dNTP, 1.25 μM of each
of the inner primers (Msc3.1-FIP and Msc3.1-BIP) and
0.25 μM of each of the outer primers (Msc3.1-F3 and
Msc3.1-B3). The reaction mix also contained 8 U Bsm
polymerase (Fermentas Thermo Scientific, St. Leon-Rot,
Germany) and 0.4 × EvaGreen® dye (20×; Biotinum Inc.,
Hayward, CA, USA). Standard reactions were run for
60 min at 58°C in an ESEQuant Tube Scanner TS95
(Qiagen, Hilden, Germany) recording fluorescence
from DNA bound EvaGreen once per minute. The
optimal reaction temperature was predetermined on a
gradient real-time cycler (StepOnePlus™; Life Technologies,
Grand Island NY, US).
Quality assurance
To allow for a quality assurance protocol, the standard
procedure for real-time PCR, melting curve analysis
(MCA) and an alternatively re-association curve analysis
was tested on a real-time platform (Rotor-Gene Q,
Qiagen, Hilden Germany). After the LAMP process, for
MCA samples were heated from 65°C to 90°C in 1°C/
min steps with consecutive measurement at each step.
For re-association of melted DNA (amplicons), reactions
were cooled down from 90°C to 65°C in the same fashion.
The amplicon inherent Tm was assessed with Oligo Calc
(http://www.basic.northwestern.edu/biotools/oligocalc.html)
and POLAND (http://www.biophys.uni-duesseldorf.de/
html/local/POLAND/poland.html).
LAMP result evaluation
LAMP is a continuous process, unlike PCR, with parallel
amplification and strand separation. Thus, only a “quasi”
exponential function can be expected in short time
increments and only the measurement of fluorescence in
intervals of 1 minute or longer presents a continuous sig-
moidal curve. For this exercise, we chose 1 min increments
to evaluate the curve and defined an increase of > 30 mV/
minute as a significant increase (Additional file 1). This
algorithm was implemented in the Tube Scanner software
and has the following limiting factors: the baseline starts
after the third measurement and ends after the seventh,
whereas the mean of the mV values represents the baseline
value (Bv). The curve is classified as positive if the increase
of signal (slope) above the mean of the baseline is > 30 mV
for a minimum of 3 measurements (Additional file 1).
The absolute time-point of detection Td (quantification)is determined when the slope increase is > 30 mV for the
first time at a tube scanner excitation intensity of 36%.
Results
Evaluation of analytical sensitivity and specificity
To evaluate the specificity of the CBPP LAMP reaction,
templates of purified DNA samples corresponding to
approximately 106 genome equivalents or suspensions of
mycoplasmal cultures corresponding to approximately
106 cells from 28 different strains of M. mycoides subsp.
mycoides and from 57 strains of 15 other related myco-
plasma species or subspecies (Additional file 1: Table S1)
were examined in the CBPP LAMP. The CBPP LAMP
gave positive signals for all 28 strains of M. mycoides subsp.
mycoides, but not for any of the other 57 mycoplasma
species. The LAMP reactions for the negative control
remained negative, even when the reactions extended
to 90 minutes.
To assess the limit of detection, a series of 10 fold
dilutions of a suspension culture of M. mycoides subsp.
mycoides strain Afadé were used as template. As shown
in Figure 1, the method detects 1000 cells per reaction
at a Time of detection (Td) of 45 minutes, while the
detection of 10 cells requires an extended analysis time
of Td = 67 minutes.
Quality assurance
For pathogen diagnosis, a quality assurance protocol is
necessary. We performed MCA, the standard for qPCR
and compared the result with the Tm for our CBPP
amplicon calculated using two methods (nearest neighbour
and Poland algorithm, respectively; Breslauer et al. [22];
Steger [23]). Interestingly, the calculated Tm (74.9°C) did
not correspond to the values measured (78.4 to 79.0°C,
dependent on the sample origin) (Figure 2). The analysis of
the inverse protocol, re-association curve analysis (RCA)
Figure 2 Melting curve and re-association curve analysis of M. mycoides subsp. mycoides type strain PG1; directly from broth culture.
The pre-determined Tm (74.9°C) corresponds to the value achieved through re-association (74.6°C) of exo-thermally separated LAMP products.
Figure 3 Calibration of the CBPP LAMP. Upper panel: Fluorometric output of LAMP amplifications using non-processed pleural fluid samples
from a CBPP infected cow. Lower panel: Titration of M. mycoides subsp. mycoides strain Afadé culture fluid at various concentrations.
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Table 3 Detection of M. mycoides subsp. mycoides in
bronchial lavage fluid of cattle that were experimentally
Mair et al. BMC Veterinary Research 2013, 9:108 Page 5 of 8
http://www.biomedcentral.com/1746-6148/9/108gave values matching the calculated ones thus allowing a
reliable QA for CBPP LAMP diagnosis.infected by contact with animals that were directly
infected 4 weeks before with M. mycoides subsp. mycoides
a) strain Afadé or b) strain L2 (Miserez et al., [15])
Days before/after
contact infection
Viable M. mycoides
subsp. mycoides / ml
Nested PCR* LAMP
- 21 - -
+ 16 - -
+ 21 - -
+ 29 - -
+ 35 - -
+ 42 - -
+ 49 - -
+ 56 - -
+ 64 - -
+ 70 - +
+ 77 1.0 × 102 + +Analysis of clinical samples
The assessment of the test performance for the crude
samples gave for the spiked samples a Td of around
45 minutes (103 Mmm/reaction). Pleural fluid samples
from two cows, with bacteriologically confirmed CBPP
taken at necropsy, resulted in Td values ranging between
20 and 35 minutes (Figure 3).
LAMP analyses of bronchial lavage samples taken se-
quentially from in-contact animals (Miserez et al. [15])
gave very similar results to the highly sensitive nested
PCR based on P72 gene encoding the lipoprotein LppA
(Tables 2, 3), showing that the CBPP LAMP was suitable
for both clinical samples from necropsy and from live
animals. The AFADE 16 samples gave identical results.
The LAMP was additionally positive 4 times and theTable 2 Detection of M. mycoides subsp. mycoides in
bronchial lavage fluid of cattle that were experimentally
infected by contact with animals that were directly
infected 4 weeks before with M. mycoides subsp.
mycoides a) strain Afadé [15] or b) strain L2 [15]
Days before/after
contact infection
Viable M. mycoides
subsp. mycoides / ml
Nested PCR* LAMP
- 28 - -
- 7 - -
+ 13 1.3 × 104 + +
+ 21 4.0 × 104 + +
+ 28 3.5 × 103 + +
+ 35 2.5 × 103 + +
+ 42 7.0 × 107 + +
+ 49 5.5 × 106 + +
+ 56 1.8 × 107 + +
+ 63 7.0 × 108 + +
+ 70 - +
+ 77 - -
+ 84 - -
+ 92 - +
+ 98 - -
+ 105 1.0 × 102 + +
+ 112 - +
+ 119 - +
+ 126 + -
+ 134 - +
+ 141 - -
+ 147 - -
* nested PCR results [15].
+ 84 + +
+ 92 2.5 × 102 + +
+ 100 3.5 × 102 + +
+ 105 8.5 × 102 + +
+ 112 1.0 × 102 + +
+ 119 1.0 × 102 + +
+ 125 1.0 × 102 + +
+ 132 + +
+ 140 - +
+ 146 - +
+ 153 + +
+ 160 + +
+ 168 - +
+ 175 + +
+ 181 + +
+ 188 1.0 × 102 + +
+ 195 1.0 × 102 + +
+ 202 - -
+ 209 - -
+ 216 - +
+ 223 - -
* nested PCR results [15].n-PCR was positive once more. For the L2 strain, 27
samples corresponded and additionally 5 times only
LAMP was positive.
Samples collected from a challenge trial in Cameroun
revealed that not only were pulmonary samples and pleural
fluids suitable forMmm detection by LAMP, but the serum
also gave valid results (Table 4).
Table 4 Experimental samples from Cameroun tested for M. mycoides subsp. mycoides (Mmm) by different methods
and LAMP; all samples were collected >45 days post intubation and showed specific pathology on post mortem PM
except 8410
Origin Specimen ID PCR cELISA Culture LAMP
Mmm inoculated cow, 8429 Serum nd + nd +
Pleural fluid + nd + +
Mmm inoculated cow, 8462 Serum nd + nd +
Pleural fluid + nd + +
Mmm inoculated cow, 05 Serum nd + nd +
Lung + nd + +
Pleural fluid + nd + +
Bov. before inoculation; 8178 Serum - nd nd -
Mmm inoculated cow, 8178 Serum nd + nd +
Mmm inoculated cow, 07 Lung + nd + +
Pleural fluid + nd + +
Mmm inoculated cow, 08 Lung + nd + +
Pleural fluid + nd + +
Mmm inoculated cow, 8454 Serum nd + nd +
Serum nd + nd +
Mmm inoculated cow, 49 Lung + nd + +
Mmm inoculated cow, 50 Lung + nd + +
Mmm inoculated cow, 56 Pleural fluid + nd + +
Mmm inoculated cow, 8410 Lung - nd nd -
Pulmon. lymph node - nd nd -
nd: not determined.
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Sensitive, reliable and time-saving molecular diagnostic
tests, vital for the successful control of CBPP, mostly rely
on TaqMan®-based real-time PCR for the detection of
the pathogen M. mycoides subsp. mycoides in extracted
and often pre-cultured clinical samples (Gorton et al. [24];
Schnee et al. [16]; Vilei and Frey [17]). Whilst these are
broadly accepted as the most specific and sensitive
method and as reference tests in control and surveillance
programs, they depend on an elaborate and expensive
laboratory infrastructure; sophisticated equipment and
personnel with advanced molecular diagnostic knowledge
hence, are not applicable to field conditions where CBPP
is endemic and where on-site diagnosis is vital to provide
confirmation of disease. A new and highly efficient iso-
thermal amplification protocol for the detection of CBPP
was developed that offers the same advantages of specifi-
city and sensitivity of the real-time PCR methodology, but
does not need the sophisticated laboratory-based equip-
ment and is thus applicable to field conditions. This was
accomplished through the design of a specific LAMP pri-
mer set for an already optimized master mix. To make the
test suitable for the field, the master and the primer mix
were lyophilized and are thus thermostable for a longerperiod (>1 year) and when rehydrated for at least one
week on the bench. Additionally, the ready mixes allow
the test to be carried out in only two pipetting steps
(sample dilution and master mix assembly) thus avoiding
errors and reducing training needs of operators.
Because the sample preparation and the amplification
steps are run in a battery-driven instrument, the test can
easily be performed at any location. The continuous
reading of the fluorescence during amplification allows a
real-time analysis of the results by the introduction of a
minimum absolute increase value for positivity thus
avoiding background problems usually faced with threshold
values. The interpretation of results simply consists of
monitoring the fluorescence increase of more than
30 mV for a minimum of two consecutive readings,
which corresponds to a positive sample. Furthermore,
these evaluation parameters can be programmed and there-
fore only the results are displayed on the instrument.
A QA procedure was established corresponding to the
published Tm prediction models (Steger [23]; Schütz and
van Ahsen [25]; Kibbe [26]). Despite the wide application of
melting curve analysis (MCA), the re-association analysis in
our setup gives the advantage of a direct correspondence to
the established prediction calculations (Breslauer et al. [22];
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parameters such as enhancers or dye factors. To perform
the re-association analysis, specific software for the
tube scanner (ESEmelt) was developed together with the
producer based on the Savitzky-Golay filter algorithm
(Savitzky and Golay [27]). False positive results due to
random amplification of non-specific target DNA or
contamination were excluded through the re-association
analysis carried directly after amplification step without
opening the vessel.
The analytical sensitivity (titration) of our test was com-
parable to the diagnostic sensitivity (clinical samples) better
than, the real-time PCR or nested PCR. As in real-time
PCR, heat-inactivated samples, after amplification, are kept
in the closed tubes to avoid cross-contamination and to
facilitate further analysis in a laboratory.
Regarding the ASSURED parameters published by
Mabey the test fulfils all criteria with the exception of
freedom from instrumentation. We believe that for a
quality assured field result quantitative parameters which
can be transmitted instantly to a reference laboratory are
important thus allowing an immediate response which
might be rather expensive.
The developed CBPP LAMP is an ideal, simple, robust
and precise method to diagnose M. mycoides subsp.
mycoides in an outbreak situation or during regular
slaughterhouse inspections in monitoring programs
for CBPP prevalence assessment.Additional file
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